These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 11488797
1. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer. McDonnell CO, Harmey JH, Bouchier-Hayes DJ, Walsh TN. Br J Surg; 2001 Aug; 88(8):1105-9. PubMed ID: 11488797 [Abstract] [Full Text] [Related]
3. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Feldman AL, Tamarkin L, Paciotti GF, Simpson BW, Linehan WM, Yang JC, Fogler WE, Turner EM, Alexander HR, Libutti SK. Clin Cancer Res; 2000 Dec; 6(12):4628-34. PubMed ID: 11156212 [Abstract] [Full Text] [Related]
4. Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer. McDonnell CO, Bouchier-Hayes DJ, Toomey D, Foley D, Kay EW, Leen E, Walsh TN. Br J Surg; 2003 Nov; 90(11):1373-8. PubMed ID: 14598417 [Abstract] [Full Text] [Related]
5. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB. J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [Abstract] [Full Text] [Related]
6. [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases]. Wang XS, Liu MZ, Zhang CQ, Cai L, Cui NJ. Ai Zheng; 2006 Nov; 25(11):1428-32. PubMed ID: 17094915 [Abstract] [Full Text] [Related]
7. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY. Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852 [Abstract] [Full Text] [Related]
8. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Coskun U, Günel N, Toruner FB, Sancak B, Onuk E, Bayram O, Cengiz O, Yilmaz E, Elbeg S, Ozkan S. Neoplasma; 2003 Jul; 50(1):41-6. PubMed ID: 12687277 [Abstract] [Full Text] [Related]
9. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer. Chin KF, Greenman J, Gardiner E, Kumar H, Topping K, Monson J. Br J Cancer; 2000 Dec; 83(11):1425-31. PubMed ID: 11076648 [Abstract] [Full Text] [Related]
11. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors? Tabone MD, Landman-Parker J, Arcil B, Coudert MC, Gerota I, Benbunan M, Leverger G, Dosquet C. Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245 [Abstract] [Full Text] [Related]
12. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H. Anticancer Res; 2002 Mar; 22(6C):3977-84. PubMed ID: 12553021 [Abstract] [Full Text] [Related]
13. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Werther K, Christensen IJ, Brünner N, Nielsen HJ. Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612 [Abstract] [Full Text] [Related]
15. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Chen CA, Cheng WF, Lee CN, Chen TM, Kung CC, Hsieh FJ, Hsieh CY. Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737 [Abstract] [Full Text] [Related]
16. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Salven P, Orpana A, Joensuu H. Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697 [Abstract] [Full Text] [Related]
17. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY. Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671 [Abstract] [Full Text] [Related]
18. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. Kulke MH, Odze RD, Mueller JD, Wang H, Redston M, Bertagnolli MM. J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710 [Abstract] [Full Text] [Related]
19. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline. Brivio F, Lissoni P, Rovelli F, Nespoli A, Uggeri F, Fumagalli L, Gardani G. Hepatogastroenterology; 2002 Jun; 49(44):385-7. PubMed ID: 11995457 [Abstract] [Full Text] [Related]